There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (ISRG – Research Report), Leap Therapeutics (LPTX – Research Report) and Elevance Health (ELV – Research Report) with bullish sentiments.
Intuitive Surgical (ISRG)
Leerink Partners analyst Mike Kratky reiterated a Buy rating on Intuitive Surgical on January 24 and set a price target of $436.00. The company’s shares closed last Thursday at $374.97, close to its 52-week high of $384.00.
According to TipRanks.com, Kratky is a 4-star analyst with an average return of
Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $399.28, which is a 7.2% upside from current levels. In a report issued on January 9, Wells Fargo also maintained a Buy rating on the stock with a $363.00 price target.
See today’s best-performing stocks on TipRanks >>
Leap Therapeutics (LPTX)
Robert W. Baird analyst Joel Beatty maintained a Buy rating on Leap Therapeutics on January 23 and set a price target of $11.00. The company’s shares closed last Thursday at $2.54, close to its 52-week low of $1.24.
According to TipRanks.com, Beatty is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Leap Therapeutics with a $12.75 average price target, which is a 394.2% upside from current levels. In a report issued on January 16, Mizuho Securities also maintained a Buy rating on the stock with a $12.00 price target.
Elevance Health (ELV)
Leerink Partners analyst Whit Mayo reiterated a Buy rating on Elevance Health on January 24 and set a price target of $565.00. The company’s shares closed last Thursday at $480.31.
According to TipRanks.com, Mayo is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elevance Health with a $569.57 average price target, implying a 20.7% upside from current levels. In a report released yesterday, Goldman Sachs also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ISRG:
- Intuitive Surgical (NASDAQ:ISRG) Clears 52-Week High; Da Vinci 5 Coming Soon
- Intuitive Surgical price target raised to $432 from $400 at RBC Capital
- Intuitive Surgical price target raised to $435 from $390 at Truist
- Intuitive Surgical price target raised to $385 from $335 at Evercore ISI
- Intuitive Surgical price target raised to $425 from $325 at Piper Sandler
